期刊文献+

改良高效液相色谱法测定血浆中顺铂磁性纳米药物的含量 被引量:6

Determination of cisplatin in plasma of rabbits by HPLC
暂未订购
导出
摘要 目的建立高效液相色谱技术测定血浆中顺铂浓度的方法来进行药物代谢动力学的研究。方法用Waters色谱系统。色谱条件:2487双通道紫外检测器。C18色谱柱(大连依利特ODS2分析柱,250mm×4.6mm,5μm),外接菲罗门C18(4mm×4 mm保护柱)。恒温35℃,流速1.0ml·min-1,流动相水-甲醇(28∶72),Waters 1525泵,717自动取样器,进样量为20μl,Breeze色谱工作站。血浆中的顺铂经二乙基二硫代氨基甲酸钠衍生化后,用氯仿提取其产物Pt(DDTC)2,离心后直接取氯仿层进样,采用高效液相色谱仪在254 nm处测定药物浓度。结果本法能有效地测定兔血浆中的顺铂浓度。样品各组分分离良好,顺铂线性范围为0.20768-12.468 mg.L-1,相关系数r=0.9999,日间和日内变异系数均小于10%。结论该方法是一种高效、准确的检测方法,适用于顺铂药物动力学的研究。 Aim To develop an HPLC method for determination of the concentrations of the cisplatin (CDDP) in plasma of rabbits. Methods The Waters HPLC system was adopted, including a 1525 pump of Waters Company, a manual 717 injector, a variable wavelength detector, an Breeze Chem Station. The analytical column was an Hypersil ODS2 clumn (250 mm x 4. 6 mm, 5 μm) with an lichrosphere C18 guard column. The column tempterature was kept in 35 ℃, The mobile phase was water and methanol in the ratio of 28 : 72. The flow rate was 1 ml · min^- l, the injected volumn of samples was 20 μl. Since CDDP could not be determined directly, the derivatization reaction with sodium diethyldithiocarbamate trihydrate (DDTC) was adopted. The plasma samples were added with 50 μl 5% DDTC ( in 0. 1 mol · L^-1sodium hydroxide solution), mixed and incubated at 37 ℃ for 30 min. The samples were then extracted with chloroform. The chloroform layer was injected 20 μl and the variable wave- length dector detected the derivatives of CDDP at the wavelength of 254 nm. Result The method could detect effectively and ac- curately the concertrations of CDDP in plasma of rabbits. The different components of samples could be seperated effectively. The linear range of CDDP was 0. 20768 - 12. 468 mg · L^-1 (r = 0. 9999 ). The RSD of intra-day and inter-day was 〈 10%. Conchmion It appears to be an accurate and effective method that fit for the Pharmacokinetic study by detecting the concentra- tion of CDDP in plasma of rabbits.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第5期692-695,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30672297) 广东省科技计划资助项目(No2006B35802002) 广州市科技计划资助项目(No2004Z3-D2091)
关键词 顺铂 高效液相色谱法 衍生化法 血浆 cisplatin HPLC derivatization plasma
  • 相关文献

参考文献7

  • 1Schurig J E, Brander W T, Haftalen J B, et al. In: Prestayko AWCrooke S T, Carter S K, eds. Cisplatin: Current Status and New Development [ M]. New York: Academic Press, 1980.
  • 2Verschraagen M, van der Born K, Zwiers TH, et al. Simμltaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci , 2002,772 (2) :273 - 81.
  • 3Lopez-Flore A, Jurado R, Garcia-Lopez P A. high-performance liquid chromarographic assay for determination of cisplatin in plasma, cancer cell, and turmor samples [ J ]. J Pharmacol Toxicol Methods,2005,52 ( 3 ) : 366 - 72.
  • 4刘祝东,刘洋,杨一昆,熊惠周,高文桂,余尧.顺铂注射液的高效液相色谱分析[J].贵金属,2001,22(2):32-35. 被引量:16
  • 5Goel R, Andrews P A, Pfeifle C E, et al. Comparison of the pharmacokinetics of μ1 tralilterablecisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy[J]. Eur J Cancer, 1990,26( 1 ) :21 -7.
  • 6Kartalou M, & Essigmann J M. Mechanisms of resistance tocisplatin[ J]. Mutation Research, 2001,478(1-2) :23 - 43.
  • 7戴春岭,李苏,梁永钜,廖海,邓文静,闫琳,符立梧.反相高效液相色谱法检测小鼠血浆中FG020326方法的建立[J].中国药理学通报,2007,23(1):131-134. 被引量:5

二级参考文献14

  • 1王秀文,丁岩,梁永钜,陈黎明,石智,杨小平,古练权,符立梧.FG020326通过增加泰素帝介导caspase-8和3激活的敏感性克服多药耐药细胞MCF-7/ADR的凋亡抗性[J].癌症,2004,23(z1):1379-1385. 被引量:10
  • 2戴春岭,符立梧.肿瘤多药耐药逆转剂的研究进展[J].中国药理学通报,2005,21(5):513-518. 被引量:39
  • 3黄天木,刘祝东.反相色谱法测定顺铂及其杂质[J].贵金属,1996,17(2):39-42. 被引量:3
  • 4黄天木 刘祝东.贵金属药物的高效液相色谱.云南省第三届色谱学术会论文集[M].,.122-123.
  • 5邓勃,分析测试数据的统计处理方法,1995年,294页
  • 6中华人民共和国卫生部药典编委会,中华人民共和国药典.二部,1995年,405页
  • 7黄天木,云南省第三届色谱学术会论文集,122页
  • 8Chen L M,Liang Y J,Fu L W,et al.Screening novel,potent multidrug-resistant modulators from imidazole derivatives[J].Oncol Res,2004,14(7-8):355-62.
  • 9Chen L M,Gu L Q,Fu L W,et al.Reversal of P-gp mediated multidrug resistance in vitro and in vivo by FG020318[J].J Pharm Pharmacol,2004,56(8):1061-6.
  • 10Bates S E,Bakke S,Kang M,et al.A phaseⅠ/Ⅱstudy of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC833) in renal cell carcinoma[J].Clin Cancer Res,2004,10(14):4724-33.

共引文献19

同被引文献16

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部